Health care providers have been reporting unprecedented shortages of prescription drugs, including vital medications such as chemotherapies and antibiotics. Under current law, the FDA has no power to act, so two senators have introduced a bill to help government get a handle on the problem.
The recent pushback on health care reform appears to have boosted the stock prices of health insurance companies, which have outperformed major indexes by quite a margin so far this year. That's because Americans have been cutting back on doctor visits, keeping reimbursement costs low.
Whistleblowing firm Ven-A-Care has recovered $2 billion for taxpayers by suing drug companies that overcharge the government and create windfalls for participating pharmacies. It also has made $380 million for itself. What's the problem with that?
Short wait times for doctor visits and 24/7 access to physicians are some of the perks available through concierge health care. But such perks cost more -- sometimes a lot more. And these plans could create a two-tier health care system.
Medical imaging and diagnostics powerhouse GE Healthcare teams up with pharmaceutical giant Johnson & Johnson to research methods of detecting Alzheimer's in patients -- even before they begin to exhibit symptoms of the devastating disease.
Just days after Johnson & Johnson's Children's Tylenol started returning to store shelves, the health care giant has recalled about four million packages of Children's Benadryl allergy tablets and some 800,000 bottles of Junior Strength Motrin, citing manufacturing problems.
A new study from Columbia University finds that the reasons America is lagging other countries aren't the commonly cited obesity, smoking, traffic fatalities and homicide. Rather, the problem has been poor health care, or rather, a poor health care system.
Global pharmaceutical sales are expected to grow by 5% to 7% in 2011, thanks to robust growth in emerging markets, especially China, as well as new innovative treatments, and despite patent expirations and budget pressures in the developed world.
A judge has finalized Allergan's $600 million settlement over the misleading marketing of its wrinkle-smoothing Botox medication. The pharmaceutical firm plead guilty to misbranding the product.
In testimony before Congress Thursday, Johnson & Johnson's CEO apologized for the problems that have beset his company, including the quality issues with its children's medicines and the "phantom recall" of a batch of Motrin. He also said new batches of its children's medicines should start shipping next week.
CEO William Weldon will apologize to Congress for a series of product recalls over the past year. The company is also expected to resume shipments of children's cold medication next week.
U.S. hospitals are doing a more effective job treating patients for heart attacks, pneumonia and surgical procedures, an independent healthcare accreditation organization said in a report released today.
